BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL

Reuters

Oct 21

Oct 21 (Reuters) - Pacira Biosciences Inc PCRX.O:

PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL®
PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPAREL
PACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUIT

Source text: ID:nGNX6XCNkV

Further company coverage: PCRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2577783018"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577783018\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577783018?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-21 20:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577783018","market":"us","top_or_hot":-1,"title":"BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL</title></head><body><p><span>Oct 21 (Reuters)</span><span> - </span>Pacira Biosciences Inc <span>PCRX.O</span>:</p><ul><li><p>PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL®</p></li><li><p>PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPAREL</p></li><li><p>PACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUIT</p></li></ul><p>Source text: <span>ID:nGNX6XCNkV</span></p><p>Further company coverage: <span>PCRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-21 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL</title></head><body><p><span>Oct 21 (Reuters)</span><span> - </span>Pacira Biosciences Inc <span>PCRX.O</span>:</p><ul><li><p>PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL®</p></li><li><p>PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPAREL</p></li><li><p>PACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUIT</p></li></ul><p>Source text: <span>ID:nGNX6XCNkV</span></p><p>Further company coverage: <span>PCRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PCRX","symbol_name":"Pacira Pharmaceuticals","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nFWN3W202I:1","article_id":"2577783018","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577783018","pubTimestamp":1761050155,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPARELOct 21 (Reuters) - Pacira Biosciences Inc PCRX.O:PACIRA BIOSCIENCES NOTIFIED OF ABBREVIA","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PCRX":"Pacira Pharmaceuticals","BK4007":"制药"},"translate_title":"简报-Pacira BioSciences收到WhiteOak集团提交的EXPAREL新药申请的通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":0.9},"content_text":"BRIEF-Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPARELOct 21 (Reuters) - Pacira Biosciences Inc PCRX.O:PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL®PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPARELPACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUITSource text: ID:nGNX6XCNkVFurther company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}